NCT04083599 2026-03-16
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Genmab
Phase 1/2 Active not recruiting
Genmab
Tesaro, Inc.
Iovance Biotherapeutics, Inc.
Shanghai Junshi Bioscience Co., Ltd.
Cantargia AB
Nektar Therapeutics